Aurobindo Pharma Ltd.
BSE: 524804 | Sector: Health care |
NSE: AUROPHARMA | ISIN Code: INE406A01037 |
BSE 00:00 | 20 May | 557.85 |
34.95 (6.68%) |
OPEN
524.50 |
HIGH
559.80 |
LOW
524.05 |
NSE 00:00 | 20 May | 557.95 |
35.10 (6.71%) |
OPEN
523.00 |
HIGH
559.65 |
LOW
523.00 |
OPEN | 524.50 |
PREVIOUS CLOSE | 522.90 |
VOLUME | 270164 |
52-Week high | 1043.00 |
52-Week low | 521.00 |
P/E | 21.43 |
Mkt Cap.(Rs cr) | 32,684 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Aurobindo Pharma Ltd. (AUROPHARMA) - Latest News & Headlines
-
Aurobindo hits 2-year low; dips 11% in a week on USFDA's 6 observations
12.42 pm | 17 May 2022 | Business Standard
Analysts at ICICI Securities expect Aurobindo Pharma's adjusted PAT to de-grow 30.4 per cent year-on-year (YoY) to Rs 557.90 crore in the March 2022 q...
-
Aurobindo's Veritaz acquisition unlikely to add much value: Analysts
4.42 pm | 29 Mar 2022 | Business Standard
Deal is nonetheless a stepping stone in the drug firm's strategic plan to focus on domestic formulations market, where it aims to have Rs 1,000-cr sal...
-
Aurobindo Pharma acquires Veritaz' domestic business for Rs 171 cr
12.18 am | 29 Mar 2022 | Business Standard
Move marks Aurobindo's increasing focus on Indian market
-
Nifty Pharma may have bottomed out; Aurobindo, Glenmark can rally up to 10%
12.54 pm | 21 Mar 2022 | Business Standard
The Nifty Pharma index has crossed its near-term resistance at 13,700, and may spurt another 1.5 per cent.
-
Select pharma shares gain on tie-up for Pfizer Covid-19 oral treatment drug
12.29 pm | 21 Mar 2022 | Business Standard
Among individual stocks, Aurobindo Pharma was the top gainer, which rallied 8 per cent to Rs 688.90 on the BSE in intra-day trade.
-
Aurobindo Pharma net profit dips 22% to Rs 604 cr in December quarter
8.04 pm | 9 Feb 2022 | Press Trust of India
The Hyderabad-based drug maker had reported a consolidated net profit of Rs 777.3 crore in the same period of previous fiscal
-
Aurobindo Pharma down 5% on USFDA warning letter for Hyderabad unit
1.05 am | 15 Jan 2022 | Business Standard
The company believes that this will not impact the existing business from this facility.
-
Stocks to Watch: Hero MotoCorp, Aurobindo, Neogen, SPARC, telecom shares
7.41 am | 6 Dec 2021 | Business Standard
Telecom shares may be in demand on credit of bank guarantee to the telcos
-
Hero MotoCorp, Lupin, Colgate, Aurobindo, Amara Raja hit 52-week lows
3.11 pm | 22 Nov 2021 | Business Standard
In past four trading days, the S&P BSE Sensex has tanked 4 per cent or 2,412 points on concerns about European Covid-19 curbs and on risk of the US Fe...
Quick Links for Aurobindo Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices